Distinct iron metabolism regulation during cachexia progression in murine models of intestinal and pancreatic cancer

Authors:

Abstract
Background: Cancer cachexia is a multifactorial syndrome characterized by substantial metabolic disturbances including systemic inflammation, and muscle atrophy, which may affect the regulation of iron metabolism in patients. This study aimed to characterize this regulation in two murine models of colorectal and pancreatic cancer, both associated with a high prevalence of cachexia. Methods: Histological, biochemical and molecular analyses were performed in serum, skeletal muscle, liver, spleen and tumor from UN-KC-6141 pancreatic tumor bearing mice and from Apc Min/+ mice (colorectal cancer model), both models exhibiting variable cachexia severity. Results: Both models induce cachexia, but diverge markedly in their regulation of iron metabolism. UNKC mice display reduced plasma iron availability (-9.6% transferrin saturation, pApc Min/+ mice exhibit anemia together with hepatic and splenic iron depletion (-48.4%, pApc Min/+ mice, iron deficiency is associated with decreased FPN and ferritin (-87.9%, pApc Min/+ colorectal cancer model. In pancreatic cancer, hepatic hepcidin is upregulated, likely in response to inflammation, and induces splenic iron sequestration, resulting in decreased plasma iron availability. In colorectal cancer, cachexia is associated with anemia together with splenic and hepatic iron depletion, whose signals probably drive hepcidin downregulation despite inflammation. Whatever the model, skeletal muscle appears to engage cellular adaptive regulatory mechanisms to preserve itself from the systemic iron dysregulation induced by cancer cachexia and its associated features.

This publication has 39 references indexed in Scilit: